We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cancer Control Following Polypectomy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00591279
First Posted: January 11, 2008
Last Update Posted: February 2, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Cancer Institute (NCI)
Mount Sinai Hospital, New York
Minneapolis Veterans Affairs Medical Center
Medical College of Wisconsin
St. Lukes hospital in Racine, Wiscousin
Massachusetts General Hospital
Cedars-Sinai Medical Center
Valley Presbyterian Hospital
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
December 26, 2007
January 11, 2008
February 2, 2017
February 1981
January 2017   (Final data collection date for primary outcome measure)
evaluate strategies for the surveillance of post-polypectomy patients [ Time Frame: 6 years ]
Not Provided
Complete list of historical versions of study NCT00591279 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Cancer Control Following Polypectomy
Cancer Control Following Polypectomy
This study evaluates strategies for the surveillance of post-polypectomy patients for the control of bladder cancer
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
fecal occult blood
Probability Sample
Patients undergoing colorectal cancer screening
Colon Cancer
Not Provided
  • A
    Barium enema and colonoscopy at one and three years after entry.
  • B
    Barium enema and colonoscopy at three years only after entry.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
110
January 2017
January 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • referral for colonoscopy or
  • referral for proctoscopy or for a complete colonoscopy after a proctoscopy or flexible sigmoidoscopy

Exclusion Criteria:

  • prior history of colon cancer, unrelated polypectomy, inflammatory bowel disease, family history of familial polyposis
Sexes Eligible for Study: All
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00591279
81-035
No
Not Provided
Not Provided
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
  • National Cancer Institute (NCI)
  • Mount Sinai Hospital, New York
  • Minneapolis Veterans Affairs Medical Center
  • Medical College of Wisconsin
  • St. Lukes hospital in Racine, Wiscousin
  • Massachusetts General Hospital
  • Cedars-Sinai Medical Center
  • Valley Presbyterian Hospital
Principal Investigator: Sidney Winawer, MD Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
January 2017